Intravenous Immunoglobulin Preparations and Autoimmune Disorders: Mechanisms of Action

E-ISSN： 1873-4316|4|4|239-247

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.4, Iss.4, 2003-08, pp. : 239-247

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravenous Immunoglobulin Therapy in Dermatologic Disorders

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 7, Iss. 2, 2008-06 ,pp. : 75-84

Bentham Science Publishers

Access to resources Recommend Favorite

Update on Intravenous Immunoglobulins (IVIg) Mechanisms of Action and Off- Label use in Autoimmune Diseases

Current Pharmaceutical Design, Vol. 17, Iss. 29, 2011-10 ,pp. : 3166-3175

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of autoimmune mucocutaneous blistering diseases with intravenous immunoglobulin therapy

By Ahmed A Razzaque

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 8, 2004-08 ,pp. : 1019-1032

Informa Healthcare

Access to resources Recommend Favorite

Current Proposed Mechanisms of Action of Intravenous Immunoglobulins in Inflammatory Neuropathies

Current Neuropharmacology, Vol. 7, Iss. 4, 2009-12 ,pp. : 337-342

Bentham Science Publishers

Access to resources Recommend Favorite

Adverse Effects of Intravenous Immunoglobulin Therapy

By Nydegger U.E.

Drug Safety, Vol. 21, Iss. 3, 1999-09 ,pp. : 171-185

Adis International

Access to resources Recommend Favorite